Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-080634
Filing Date
2020-03-20
Accepted
2020-03-20 16:04:32
Documents
2
Effectiveness Date
2020-03-20

Document Format Files

Seq Description Document Type Size
1 DEFA14A d860220ddefa14a.htm DEFA14A 15909
2 GRAPHIC g860220page002.jpg GRAPHIC 268278
  Complete submission text file 0001193125-20-080634.txt   386585
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36076 | Film No.: 20731996
SIC: 2836 Biological Products, (No Diagnostic Substances)